These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1720834)

  • 21. A dose-finding, placebo-controlled study on extended-release felodipine once daily in treatment of hypertension.
    Cambell LM; Ross JR; Goves JR; Lees CT; McCullagh A; Barnes P; Timerick SJ; Richardson PD
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):869-73. PubMed ID: 2481775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S; Aurup P; Snavely D; Goldberg A
    Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of felodipine and hydrochlorothiazide for the treatment of mild to moderate hypertension in black Africans.
    Leary WP; Maharaj B
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S91-3. PubMed ID: 1693738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
    Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of felodipine and metoprolol on blood pressure, plasma renin, angiotensin II, aldosterone and catecholamines in hypertensive patients.
    Lijnen P; Fagard R; Staessen J; Moerman E; De Schaepdryver A; Amery A
    Drugs; 1987; 34 Suppl 3():170-5. PubMed ID: 3327678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
    Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1986; 30(2):151-6. PubMed ID: 3519243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and tolerability of long-term felodipine treatment in hypertension. The Scandinavian Multicenter Group.
    Ibsen H; Westberg B
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):641-7. PubMed ID: 1981681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-release felodipine in patients with mild to moderate hypertension. Felodipine ER Dose-Response Study Group.
    Weber MA; Goldberg AI; Faison EP; Lipschutz K; Shapiro DA; Nelson EB; Irvin JD
    Clin Pharmacol Ther; 1994 Mar; 55(3):346-52. PubMed ID: 8143399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of CYP11B2 gene -344T/C polymorphism on renin-angiotensin-aldosterone system activity and blood pressure response to hydrochlorothiazide].
    Li Y; Yang P; Wu SL; Yuan JX; Wu Y; Zhao DD; Xu S; Zhao LP; Sun MJ; Chu LM; Lu DS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):68-71. PubMed ID: 22311496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-four-hour antihypertensive efficacy of felodipine 10 mg extended-release: the Italian inter-university study.
    Pannarale G; Puddu PE; Monti F; Irace L; Bentivoglio M; Collauto F; Barsotti A; Corea L; Trevi G; Campa PP; Jacono A
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):255-61. PubMed ID: 8720425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG; Fox AA; Stimpel M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
    Dorresteijn JA; Schrover IM; Visseren FL; Scheffer PG; Oey PL; Danser AH; Spiering W
    J Hypertens; 2013 Feb; 31(2):393-403. PubMed ID: 23235355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.
    Weintraub HS; Duprez DA; Cushman WC; Zappe DH; Purkayastha D; Samuel R; Izzo JL
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):145-55. PubMed ID: 22311004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
    Dahlöf B; Herlitz H; Aurell M; Hansson L
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of felodipine, metoprolol and their combination on blood pressure at rest and during exercise and on volume regulatory hormones in hypertensive patients.
    Gordon RD; Klemm SA; Tunny TJ; Wicks JR; Elmfeldt DB
    Blood Press; 1995 Sep; 4(5):300-6. PubMed ID: 8535552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo.
    Bossini A; Di Veroli C; Cavallotti G; Cagli V
    Br J Clin Pharmacol; 1990 Oct; 30(4):567-71. PubMed ID: 2291869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.